FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters

Links shared publicly online about this topic.

  • 1,672
    total visits

FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters

reuters.com

PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types

View full resource at reuters.com

Tags: Cervical Cancer, Cervical Cancer Prevention, Drug, FDA, Vaccine, HPV Vaccine, Cervarix, GlaxoSmithKline

  • Share

Most Recently Shared on October 16, 2009 at 5:12 pm By:

sknews Skin & Allergy News

RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D

2 years ago...

FDA approves Cevarix for HPV and cervical cancer prevention - WEGO Health

community.wegohealth.com — “Time to watch your TV for more HPV (Genital human papillomavirus) commercials, Gardasil now has competition! As of this Friday, GlaxoSmithKline's Cevarix vaccination has been approved by the US Food & Drug Administration according to the Associated Press. Cervarix, like Gardasil, will inhibit strains 16 and 18 of HPV - two strains which cause 75% of cervical cancers. Although there are more than 100 identified strains of the human papillomavirus, only about 15 are known to cause cervical canView full resource at community.wegohealth.com

  • View Related
  • Share

Most Recently Shared on October 17, 2009 at 2:08 pm By:

timsander Our Aloe Business Health Business

FDA approves Cevarix for HPV and cervical cancer prevention http://bit.ly/3IJsIO

2 years ago...

FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine

drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 10:45 pm By:

drugscom Drugs.com Health Site

FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0

2 years ago...

FDA Clears Glaxo's Cervarix Vaccine - WSJ.com

online.wsj.com — “U.S. regulators approved GlaxoSmithKline's Cervarix vaccine designed to protect against cervical cancer in women.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 9:09 pm By:

Cervarix approved for prevention of HPV-associated cervical cancer - MPR

empr.com — “The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and women 10"25 years of age.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 8:55 pm By:

eMPR MPR Medical Publisher

MPR News: Cervarix approved for prevention of HPV-associated cervical cancer: The FDA has approved Cerv.. http://bit.ly/WF8uF

2 years ago...

FDA approves Glaxo's cervical cancer vaccine - Health- msnbc.com

msnbc.msn.com — “British drugmaker GlaxoSmithKline said Friday U.S. regulators approved its vaccine Cervarix to prevent the leading cause of cervical cancer in women.View full resource at msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 7:37 pm By:

FDA Clears Glaxo's Cervarix Vaccine - WSJ.com

online.wsj.com — “U.S. regulators approved GlaxoSmithKline's Cervarix vaccine designed to protect against cervical cancer in women.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 4:40 pm By:

U.S. approves Glaxo's cervical cancer vaccine | Reuters

feeds.reuters.com — “WASHINGTON (Reuters) - GlaxoSmithKline PLC won U.S. approval on Friday to sell a long-delayed vaccine against the virus that causes cervical cancer. The British company's Cervarix vaccine will competeView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 3:57 pm By:

UPDATE 1-Glaxo wins Japanese approval for Cervarix | Reuters

reuters.com — “* First cervical cancer to win approval in Japan * Merck's Gardasil awaiting green light (Adds details, background) LONDON, Oct 16 (Reuters) - Japanese authorities have approved GlaxoSmithKline'sView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 16, 2009 at 3:10 pm By:

reutersBenHir Ben Hirschler Health Communicator

At last, #Glaxo gets #FDA approval for Cervarix - but how much business has Gardasil left on the table? http://tinyurl.com/yh5e7tv

2 years ago...

FDA delays decision on Cervarix; GSK recalls vaccine in U.K. - Related Stories - AAP SmartBrief

smartbrief.com — “The FDA delayed again its decision to approve cervical cancer vaccine Cervarix to further review GlaxoSmithKline's application. The agency's announcement came the same day GSK recalled a batch of Cervarix in the U.K. because a 14-year-old girl died after getting vaccinated. <a href='/servlet/aaRedirView full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on October 1, 2009 at 1:49 am By:

songMD Clara Song Pediatrician, Physician, and Doctor

FDA delays decision on Cervarix; GSK recalls vaccine in U.K. http://sbne.ws/r/2UZl

3 years ago...

WRAPUP1-Glaxo's Cervarix vaccine faces delays, concerns | Reuters

reuters.com — “* FDA needs more time to weigh product * No indication delay is linked to UK death * Vaccine batch recalled following teenager's death * Cervarix gets support in Japan By Susan Heavey WASHINGTON,View full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 29, 2009 at 7:55 pm By:

KQEDhealth KQED Public Radio Health News

14 yr old dies shortly after getting Glaxo's Cervarix (cervical cancer) vaccine in Britain, U.S. delays vaccine approval http://ow.ly/rI0v

3 years ago...

FDA approves second cervical cancer vaccine, Cervarix, for preventing HPV in women

nydailynews.com — “Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women.View full resource at nydailynews.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 3:34 pm By:

NYDNlifestyle NYDN Lifestyle Health Site

FDA backs new HPV vaccine, Cervarix: Federal health officials said Wednesday a long-delayed vaccine from GlaxoSm.. http://bit.ly/30QPTi

3 years ago...

FDA panel backs Glaxo's cervical vaccine for women

physorg.com — “(AP) -- Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers.View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on September 10, 2009 at 12:19 am By:

FightCancer FightCancer Health News

FDA panel backs Glaxo's cervical vaccine for women http://bit.ly/1Zasoh

3 years ago...

FDA panel backs Glaxo cervical cancer vaccine | Reuters

reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsementView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 9, 2009 at 9:05 pm By:

ONClive Editor Oncology

Big news for Glaxo: ODAC backs approval of Cervarix for females aged 10 to 25. http://tiny.cc/mopeE

3 years ago...

FDA panel backs Glaxo cervical cancer vaccine | Reuters

reuters.com — “GAITHERSBURG, Maryland (Reuters) - GlaxoSmithKline PLC's proposed cervical cancer vaccine is safe and effective for girls and young women ages 10 to 25, a U.S. advisory panel said on Wednesday. The endorsementView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 9, 2009 at 7:01 pm By:

Advertisement